Home › Kanser sa Baga
Pag-aaral pangklinika para sa Kanser sa Baga na nagre-recruit sa U.S.
349 pag-aaral para sa Kanser sa Baga ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX78 pag-aaral
- Boston, MA63 pag-aaral
- New York City, NY60 pag-aaral
- Los Angeles, CA45 pag-aaral
- Chicago, IL43 pag-aaral
- Arlington, VA42 pag-aaral
- Washington, DC41 pag-aaral
- Baltimore, MD41 pag-aaral
- Nashville, TN39 pag-aaral
- St. Louis, MO37 pag-aaral
- Columbus, OH36 pag-aaral
- Philadelphia, PA36 pag-aaral
- Seattle, WA34 pag-aaral
- Durham, NC33 pag-aaral
- Tampa, FL31 pag-aaral
- Atlanta, GA28 pag-aaral
- San Antonio, TX27 pag-aaral
- Portland, OR27 pag-aaral
- Dallas, TX26 pag-aaral
- San Diego, CA26 pag-aaral
- Cleveland, OH26 pag-aaral
- Edison, NJ25 pag-aaral
- Pittsburgh, PA24 pag-aaral
- New Haven, CT24 pag-aaral
- Baldwin Park, CA23 pag-aaral
- Ann Arbor, MI23 pag-aaral
- Orlando, FL23 pag-aaral
- San Francisco, CA23 pag-aaral
- Sacramento, CA23 pag-aaral
- Queens, NY22 pag-aaral
- Miami, FL22 pag-aaral
- Rochester, MN21 pag-aaral
- Milwaukee, WI21 pag-aaral
- Mountain View, CA20 pag-aaral
- Oklahoma City, OK20 pag-aaral
- Minneapolis, MN20 pag-aaral
- Salt Lake City, UT19 pag-aaral
- Aurora, CO19 pag-aaral
- Detroit, MI19 pag-aaral
- Evanston, IL19 pag-aaral
Ayos sa estado
- Alabama15 pag-aaral
- Alaska9 pag-aaral
- Arizona34 pag-aaral
- Arkansas19 pag-aaral
- California114 pag-aaral
- Colorado38 pag-aaral
- Connecticut32 pag-aaral
- Delaware11 pag-aaral
- District of Columbia27 pag-aaral
- Florida79 pag-aaral
- Georgia40 pag-aaral
- Hawaii8 pag-aaral
- Idaho12 pag-aaral
- Illinois65 pag-aaral
- Indiana24 pag-aaral
- Iowa21 pag-aaral
- Kansas20 pag-aaral
- Kentucky25 pag-aaral
- Louisiana15 pag-aaral
- Maine12 pag-aaral
- Maryland56 pag-aaral
- Massachusetts76 pag-aaral
- Michigan45 pag-aaral
- Minnesota42 pag-aaral
- Mississippi15 pag-aaral
- Missouri44 pag-aaral
- Montana13 pag-aaral
- Nebraska19 pag-aaral
- Nevada9 pag-aaral
- New Hampshire12 pag-aaral
- New Jersey43 pag-aaral
- New Mexico15 pag-aaral
- New York92 pag-aaral
- North Carolina50 pag-aaral
- North Dakota15 pag-aaral
- Ohio66 pag-aaral
- Oklahoma21 pag-aaral
- Oregon31 pag-aaral
- Pennsylvania57 pag-aaral
- Rhode Island6 pag-aaral
- South Carolina22 pag-aaral
- South Dakota14 pag-aaral
- Tennessee58 pag-aaral
- Texas101 pag-aaral
- Utah22 pag-aaral
- Vermont8 pag-aaral
- Virginia60 pag-aaral
- Washington44 pag-aaral
- West Virginia11 pag-aaral
- Wisconsin33 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT05920356A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07063745Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06780098EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06716580Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06909201Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07100080Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Nagre-recruitObservasyonal na pag-aaral
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT01950572This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06758401Evaluation for NCI Surgery Branch Clinical Research Protocols
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT00001823Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06498635BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07625644Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04267848Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
Nagre-recruit
Edad 50 hanggang 80 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07168993Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Nagre-recruitPhase 3
Edad 70 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06096844A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07458347A Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening Rates in Eligible High Risk Patients
Nagre-recruit
Edad 50 hanggang 77 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07322367Detection of Genetic Markers of Lung Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT00280202A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07020221A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT06312137A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07099898Collection of Blood From Patients With Cancer
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT00034216Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07664579Health Opportunities and Promoters of Equitable Screening for Lung Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 50 hanggang 80 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT05784922Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT00451022Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06881784Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.